Covered recipient · General Payments record
MICHAEL A JENNINGS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,716.05
- Reported across 134 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $487.77 | 34 |
| Education | $11.56 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $172.92 | 17 |
| Acerta Pharma LLC | $136.26 | 7 |
| ABBVIE INC. | $68.15 | 4 |
| E.R. Squibb & Sons, L.L.C. | $28.84 | 2 |
| Xeris Pharmaceuticals, Inc. | $24.27 | 1 |
| ABIOMED | $19.88 | 1 |
| DEXCOM, INC. | $19.76 | 1 |
| Novo Nordisk AS | $14.77 | 1 |
| Lilly USA, LLC | $14.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.21 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103993573 | CMS |
| ABBVIE INC. | $14.16 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103993575 | CMS |
| ABBVIE INC. | $17.94 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103993577 | CMS |
| ABBVIE INC. | $17.84 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103993579 | CMS |
| ABIOMED | $19.88 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142266022 | CMS |
| AstraZeneca Pharmaceuticals LP | $36.44 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105681987 | CMS |
| AstraZeneca Pharmaceuticals LP | $6.50 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104769126 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.44 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105554976 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.57 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104454584 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.84 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104544446 | CMS |
| AstraZeneca Pharmaceuticals LP | $11.56 | 10/29/2024 | Education | Undisputed | 01/23/2026 | 1105841213 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.91 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105242679 | CMS |
| Dexcom, Inc. | $19.76 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153322210 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.38 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101246344 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.46 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101246384 | CMS |
| Lilly USA, LLC | $14.48 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135186109 | CMS |
| Novo Nordisk Inc | $14.77 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096758088 | CMS |
| PFIZER INC. | $11.91 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130887721 | CMS |
| PFIZER INC. | $8.89 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131711199 | CMS |
| PFIZER INC. | $4.31 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131814416 | CMS |
| PFIZER INC. | $9.28 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130884412 | CMS |
| PFIZER INC. | $14.49 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131277347 | CMS |
| PFIZER INC. | $7.78 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131712702 | CMS |
| PFIZER INC. | $6.62 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131715630 | CMS |
| PFIZER INC. | $6.93 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131724034 | CMS |
| PFIZER INC. | $15.03 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131470184 | CMS |
| PFIZER INC. | $15.08 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131615179 | CMS |
| PFIZER INC. | $13.08 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131495872 | CMS |
| PFIZER INC. | $2.58 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131735984 | CMS |
| PFIZER INC. | $10.53 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131778936 | CMS |
| PFIZER INC. | $15.69 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131790273 | CMS |
| PFIZER INC. | $6.95 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132075379 | CMS |
| PFIZER INC. | $10.21 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131120793 | CMS |
| PFIZER INC. | $13.56 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131099175 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.27 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144605874 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.